Comparison of safety and efficacy of Oral Terbinafine with Amphotericin B gel and Sertaconazole cream for the treatment of Tinea Corporis and its effect on quality of life of patients
Journal Title: International Journal of Dermatology and Clinical Research - Year 2017, Vol 3, Issue 1
Abstract
Background: Tinea Corporis is a superficial fungal infection affecting 20-25% of the world’s population. Management involves using topical and oral antifungal drugs. Terbinafine has been used commonly for the treatment of tinea corporis to prevent the emergence of resistance combination of drugs is used. Hence, this study was designed to compare the safety and efficacy of Sertaconazole and Amphotericin B when either is used with oral Terbinafine. Methodology: This open-label, randomized, prospective and parallel group study was conducted on patients suffering from tinea corporis visiting the Department of Dermatology. All patients underwent a thorough clinical examination to establish the diagnosis of tinea corporis and were divided into two groups. Patients in Group A received treatment with Sertaconazole and Terbinafine. Group B received treatment with Amphotericin B and Terbinafine. At the end of treatment phase patients were assessed clinically for the disease symptoms - erythema, pruritus, and scaling; adverse effects experienced and Dermatological life quality index (DLQI). Results: Fifty two (52) patients were enrolled in the study, both groups were comparable at baseline. After 2 weeks of treatment, complete clinical cure was found in 6 patients in Group A and 5 patients in Group B. The treatment also showed improvement in clinical disease activity as there was clinical improvement seen in 22 patients in group A as compared to 25 patients in Group B. Greater number of patients in Group B reported with symptomatic improvement. There was no serious adverse event reported in both groups and DLQI score was comparable. Conclusion: The use of topical antifungals along with systemic antifungals has been found to be useful in early achievement of clinical cure and improvement in clinical symptoms of tinea corporis.
Authors and Affiliations
Sirohi Sumedha, Bhutani Sumit, Cheema Cherry, Kaur Gurleen, Singh SP, Matreja Prithpal S
Keywords
Related Articles
- EP ID EP341578
- DOI 10.17352/2455-8605.000021
- Views 51
- Downloads 0
Schamberg Disease in a 54-Year-Old Chinese Woman
Schamberg disease, also known as Schamberg purpura or progressive pigmentary purpura, is characterized by orange-brown or reddish-brown macules/patches with overlaying purpuric spots simulating “cayenne pepper”. We repor...
Topical Curcumin: A Review of Mechanisms and uses in Dermatology
Curcumin, the active ingredient in the spice turmeric, has been used in many Eastern countries for its known anti-inflammatory activity. Recently, analysis of multiple studies have cast doubt with regard to the efficacy...
Successful Treatment of Annular Elastolytic Giant Cell Granuloma with Tranilast and Topical Glucocorticoid under the Strict Restriction of Sun Exposure
Annular elastolylic giant cell granuloma (AEGCG) is a rare granulomatous skin disease characterized by loss of elastic fibers accompanied with elastophagocytosis by multinucleated giant cells. The clinical appearance sho...
A Case of Actinomycetoma Treated with Trimethoprim + Sulfamethoxazole
A 32-year-old man presented with a history of progressive, painful nodular growths with discharge consisting granules over the right thigh, inguinal area and right foot. Histopathological examination of the tissue biopsy...
A Case of Jessner’s Lymphocytic Infiltrate and Cutaneous B-Cell Follicular Lymphoma: Coexistence or Transformation?
Jessner’s lymphocytic infiltrate of the skin is a rare, benign cutaneous disorder. Difficulty arises in differentiating it from cutaneous lymphoma on histology, thus requiring immunophenotying, however the literature lac...